Ion Beam ApplicationsIOBCF -0.74%82 Cyclically Adjusted PB Ratio is 3.36 as of Jul. 02, 2026, which is 1% below its 10-year median of 3.38. GuruFocus rates IOBCF with a GF Score™ of 82/100 and a GF Value™ of $18.71 (Fairly Valued). The stock has 10 warning signs investors should review. Among 524 Medical Devices & Instruments companies, Ion Beam Applications ranks worse than 72.52% on this metric.
The historical rank and industry rank for Ion Beam Applications's Cyclically Adjusted PB Ratio or its related term are showing as below:
IOBCF'
s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.68 Med: 3.38 Max: 11.92
Current: 3.53
During the past 13 years, Ion Beam Applications's highest Cyclically Adjusted PB Ratio was 11.92. The lowest was 1.68. And the median was 3.38.
IOBCF's Cyclically Adjusted PB Ratio is ranked worse than 72.52% of 524
companies
in the Medical Devices & Instruments industry
Industry Median: 1.775
vs IOBCF: 3.53
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
Ion Beam Applications's adjusted book value per share data of for the fiscal year that ended in Dec25 was $5.068. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $5.61 for the trailing ten years ended in Dec25.
Shiller PE for Stocks: The True Measure of Stock Valuation
Ion Beam Applications (OTCPK:IOBCF) Cyclically Adjusted PB Ratio Explanation
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Ion Beam Applications Cyclically Adjusted PB Ratio Related Terms
Ion Beam Applications Cyclically Adjusted PB Ratio Historical Data
* Premium members only.
The historical data trend for Ion Beam Applications's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ion Beam Applications Cyclically Adjusted PB Ratio Chart
IOBCF vs ABT, SYK, MDT: Cyclically Adjusted PB Ratio Comparison
For the Medical Devices subindustry, Ion Beam Applications's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ion Beam Applications Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ion Beam Applications's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where Ion Beam Applications's Cyclically Adjusted PB Ratio falls into.
Ion Beam Applications Cyclically Adjusted PB Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PB Ratio of 3.36 mean?
Ion Beam Applications (IOBCF) has a Cyclically Adjusted PB Ratio of 3.36 as of Jul. 02, 2026. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Ion Beam Applications and its competitors. This is near median its historical median of 3.38. Over the past decade, Ion Beam Applications' Cyclically Adjusted PB Ratio has ranged from 1.68 to 11.92. According to the industry distribution chart, Ion Beam Applications ranks #380 out of 524 companies in the Medical Devices & Instruments industry, placing it in the top 72.5%.
Is Ion Beam Applications' Cyclically Adjusted PB Ratio too high?
Ion Beam Applications' current Cyclically Adjusted PB Ratio of 3.36 is near median its 10-year median of 3.38. Over the past 10 years, this metric has ranged from a low of 1.68 to a high of 11.92. The Medical Devices & Instruments industry median Cyclically Adjusted PB Ratio is 1.78. Ion Beam Applications' value of 3.36 is 89.3% above this industry median. Based on the distribution chart, Ion Beam Applications ranks #380 out of 524 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Ion Beam Applications has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ion Beam Applications' Cyclically Adjusted PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ion Beam Applications ranks #380 out of 524 companies for Cyclically Adjusted PB Ratio. This places Ion Beam Applications in the lower half of its industry. The industry median Cyclically Adjusted PB Ratio is 1.78. Ion Beam Applications' value of 3.36 is 89.3% above this benchmark. Historically, Ion Beam Applications' own Cyclically Adjusted PB Ratio has ranged from 1.68 to 11.92 over the past decade. While the company's 10-year median is 3.38 vs. the industry median of 1.78, Ion Beam Applications has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PB Ratio for a Medical Devices & Instruments company?
The median Cyclically Adjusted PB Ratio among Medical Devices & Instruments companies is 1.78, based on 524 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ion Beam Applications's current Cyclically Adjusted PB Ratio of 3.36 is 89.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PB Ratio mean?
A high Cyclically Adjusted PB Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Ion Beam Applications and its competitors. For the Medical Devices & Instruments industry, the median Cyclically Adjusted PB Ratio is 1.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ion Beam Applications's current Cyclically Adjusted PB Ratio is 3.36, which is near median its own 10-year median of 3.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ion Beam Applications stock overvalued right now?
Based on GuruFocus' analysis, Ion Beam Applications (IOBCF) is currently considered Fairly Valued. The stock's GF Value™ is $18.71, compared to a current price of $18.86 — trading 0.8% above its estimated fair value. The current Cyclically Adjusted PB Ratio is 3.36, which is near median its 10-year median of 3.38 and 89.3% above the Medical Devices & Instruments industry median of 1.78. Ion Beam Applications' overall GF Score™ is 82/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PB Ratio calculated?
Cyclically Adjusted PB Ratio is calculated from a company's financial statements. For Ion Beam Applications (IOBCF), the current Cyclically Adjusted PB Ratio is 3.36 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ion Beam Applications (IOBCF) Overvalued in 2026?
Based on GuruFocus' analysis, Ion Beam Applications stock appears to be overvalued.
The current stock price of $18.86 is trading 0.8% above its estimated GF Value™ of $18.71.
GuruFocus considers Ion Beam Applications to be Fairly Valued.
Key valuation signals for IOBCF:
Cyclically Adjusted PB Ratio: 3.36 (near median its 10-year median of 3.38)
GF Value™: $18.71 vs. price of $18.86 (0.8% above fair value)
Industry Position: 89.3% above the Medical Devices & Instruments median (#380 of 524)
No single metric tells the full story. See the IOBCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in three segments: IBA Clinical, including Proton Therapy and Dosimetry; IBA Technologies; and IBA Corporate. Proton therapy and other accelerators contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, China, Germany, and India.
82GF Score
Get the complete analysis for IOBCF
Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IOBCF has been successfully added to your 
